Lectin-mediated drug targeting: History and applications

Advanced Drug Delivery Reviews

Volumn 56, Issue 4, 2004, Pages 425-435

  Bies, Christiane ^a   Lehr, Claus Michael ^a   Woodley, John F ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bioadhesion; Drug delivery; Endocytosis; Gene delivery; Lectin; Protein sugar interaction; Transcytosis; Vesicular transport

Indexed keywords

BIOLOGICAL ORGANS; BLOOD; BRAIN; CELLS; PLANTS (BOTANY); PURIFICATION;

BIOLOGICAL BARRIERS; DRUG DELIVERY; LECTINS;

DRUG PRODUCTS;

CARBOHYDRATE BINDING PROTEIN; LECTIN; PLANT LECTIN; TOMATINE; VESICULAR TRANSPORT PROTEIN; VISCUM ALBUM LECTIN;

BLOOD BRAIN BARRIER; CELL ADHESION; CHEEK MUCOSA; DRUG DELIVERY SYSTEM; DRUG SPECIFICITY; DRUG TARGETING; EPITHELIUM CELL; EYE; GASTROINTESTINAL TRACT; GENE TARGETING; LECTIN BINDING SITE; NOSE MUCOSA; PERMEABILITY BARRIER; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; SMALL INTESTINE MUCOSA; TOMATO;

EID: 1142309558     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.030     Document Type: Article

References (79)

1. H. Stillmark, R. Über, ein giftiges Ferment aus den Samen von Ricinus comm. L. und einigen anderen Euphorbiaceen (1888), M.D. Dissertation, University of Dorpat, Dorpat.
2. Kilpatrick D.C. Animal lectins: a historical introduction and overview. Biochim. Biophys. Acta. 1572:2002;187-197.
3. Boyd W.C., Shapleigh E. Specific precipitating activity of plant agglutinins (lectins). Science. 119:1954;419.
4. Sharon N., Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science. 177:1972;949-959.
5. Haltner E., Easson J., Lehr C.M. Lectins and bacterial invasion factors for controlling endo- and transcytosis of bioadhesive drug carrier systems. Eur. J. Pharm. Biopharm. 44:1997;3-13.
6. Woodley J.F., Naisbett B. The potential of lectins for delaying the intestinal transit of drugs. Proc. Int. Symp. Control Rel. Bioact. Mater. 15:1988;125-126.
7. Jiménez-Catelanos M.R., Zia H., Rhodes C.T. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 19:1993;143-194.
8. Kilpatrick D.C. Purification and some properties of a lectin from the fruit juice of the tomato (Lycopersicon esculentum). Biochem. J. 185:1980;269-272.
9. Kilpatrick D.C., Pusztai A., Grant G., Graham C., Ewen S.W. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett. 185:1985;299-305.
10. Kilpatrick D.C., Weston J., Urbaniak S.J. Purification and separation of tomato isolectins by chromatofocusing. Anal. Biochem. 134:1983;205-209.
11. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery: 1. Lectin binding to rat small intestine in vitro. Int. J. Pharm. 107:1994;223-230.
12. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery: 2. Mechanism of uptake in vitro. Int. J. Pharm. 110:1994;127-136.
13. Naisbett N., Woodley J. The potential use of tomato lectin for oral drug delivery: 3. Bioadhesion in vivo. Int. J. Pharm. 114:1995;227-236.
14. Lehr C.M., Poelma F.G.J., Junginger H.E., Tukker J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:1991;235-240.
15. Lehr C.M., Bouwstra J.A., Kok W., Noach A.B., de Boer A.G., Junginger H.E. Bioadhesion by means of specific binding of tomato lectin. Pharm. Res. 9:1992;547-553.
16. Montisci M.J., Giovannuci G., Duchene D., Ponchel G. Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. Int. J. Pharm. 215:2001;153-161.
17. Irache J.M., Durrer C., Duchene D., Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13:1996;1716-1719.
18. Lehr C.-M., Pusztai A. The potential of bioadhesive lectins for the delivery of peptide and protein drugs to the gastrointestinal tract. Pusztai A., Bardocz S. Lectins: Biomedical Perspectives. 1995;117-140 Taylor and Francis, London.
19. Irache J.M., Durrer C., Duchene D., Ponchel G. Preparation and characterization of lectin-latex conjugates for specific bioadhesion. Biomaterials. 15:1994;899-904.
20. Montisci M.J., Dembri A., Giovannuci G., Chacun H., Duchene D., Ponchel G. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm. Res. 18:2001;829-837.
21. Lehr C.M., Lee V.H. Binding and transport of some bioadhesive plant lectins across Caco-2 cell monolayers. Pharm. Res. 10:1993;1796-1799.
22. Russell-Jones G.J., Veitch H., Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190:1999;165-174.
23. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
24. Hussain N., Jani P.U., Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14:1997;613-618.
25. Easson J.H., Haltner E., Lehr C.-M., Jahn D. Bacterial invasion factors and lectins as second-generation bioadhesives. Mathiowitz E., et al. Bioadhesive Drug Delivery Systems - Fundamentals, Novel Approaches and Developments. 1999;409-432 Marcel Dekker, New York.
26. Hussain N., Florence A.T. Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res. 15:1998;153-156.
27. Russell-Jones G.J. The potential use of receptor-mediated endocytosis for oral drug delivery. Adv. Drug Deliv. Rev. 46:2001;59-73.
28. Izhar M., Nuchamowitz Y., Merelman D. Adherence of Shigella Flexneri to guinea pig intestinal cells is mediated by mucosal adhesin. Infect. Immun. 35:1982;1110-1118.
29. Ashkenazi S. Adherence of non-fimbriated entero invasive Escherichia coli O124 to guinea pig intestinal tract in vitro and in vivo. J. Med. Microbiol. 21:1986;117-123.
30. Bridges J.F., Woodley J.F., Duncan R., Kopecek J. Soluble N-(2-hydroxypropyl) methacrylamide copolymers as a potential oral, controlled-release, drug delivery system. I. Bioadhesion to the rat intestine in vitro. Int. J. Pharm. 44:1988;213-223.
31. Ley K. The role of selectins in inflammation and disease. Trends Mol. Med. 9:2003;263-268.
32. Bernkop-Schnürch A., Gabor F., Szostak M.P., Lubitz W. An adhesive drug delivery system based on K99-fimbriae. Eur. J. Pharm. Sci. 3:1995;293-299.
33. Bernkop-Schnürch A., Gabor F., Spiegl P. Bacterial adhesins as a drug carrier: covalent attachment of K99 fimbriae to 6-methylprednisolone. Pharmazie. 52:1997;41-44.
34. Giannasca P.J., Boden J.A., Monath T.P. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect. Immun. 65:1997;4288-4298.
35. Kumar P., Timoney J.F., Sheoran A.S. M cells and associated lymphoid tissue of the equine nasopharyngeal tonsil. [comment] Equine Vet. J. 33:2001;224-230.
36. Takata S., Ohtani O., Watanabe Y. Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT. Arch. Histol. Cytol. 63:2000;305-312.
37. Kawai T., Greenberg S.D., Titus J.L. Lectin histochemistry of normal lung and pulmonary adenocarcinoma. Mod. Pathol. 1:1988;485-492.
38. Dorscheid D.R., Conforti A.E., Hamann K.J., Rabe K.F., White S.R. Characterization of cell surface lectin-binding patterns of human airway epithelium. Histochem. J. 31:1999;145-151.
39. Alvarez-Fernandez E., Carretero-Albinana L. Lectin histochemistry of normal bronchopulmonary tissues and common forms of bronchogenic carcinoma. Arch. Pathol. Lab. Med. 114:1990;475-481.
40. Yi S.M., Harson R.E., Zabner J., Welsh M.J. Lectin binding and endocytosis at the apical surface of human airway epithelia. Gene Ther. 8:2001;1826-1832.
41. Batra R.K., Wang-Johanning F., Wagner E., Garver R.I., Curiel J., Curiel D.T. Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther. 1:1994;255-260.
42. Yanagihara K., Cheng P.W. Lectin enhancement of the lipofection efficiency in human lung carcinoma cells. Biochim. Biophys. Acta. 1472:1999;25-33.
43. Fajac I., Briand P., Monsigny M. Gene therapy of cystic fibrosis: the glycofection approach. Glycoconjugate J. 18:2001;723-729.
44. Fajac I., Thevenot G., Bedouet L., Danel C., Riquet M., Merten M., Figarella C., Ava-Santucci J.D., Monsigny M., Briand P. Uptake of plasmid/glycosylated polymer complexes and gene transfer efficiency in differentiated airway epithelial cells. J. Gene Med. 5:2003;38-48.
45. Normand I.C., Olver R.E., Reynolds E.O., Strang L.B. Permeability of lung capillaries and alveoli to non-electrolytes in the foetal lamb. J. Physiol. 219:1971;303-330.
46. Taylor A.E., Gaar K.A.J. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am. J. Physiol. 218:1970;1133-1140.
47. Adamson I.Y., Bowden D.H. The type II cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab. Invest. 30:1974;35-42.
48. 2. Exp. Mol. Pathol. 22:1975;142-150.
49. Bankston P.W., Porter G.A., Milici A.J., Palade G.E. Differential and specific labeling of epithelial and vascular endothelial cells of the rat lung by Lycopersicon esculentum and Griffonia simplicifolia lectins. Eur. J. Cell Biol. 54:1991;187-195.
50. Kasper M., Migheli A. LR Gold and LR White embedding of lung tissue for immunoelectron microscopy. Acta Histochem. 95:1993;221-227.
51. Brück A., Abu-Dahab R., Borchard G., Schäfer U.F., Lehr C.M. Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells. J. Drug Target. 9:2001;241-251. (color plates I-III).
52. Abu-Dahab R., Schäfer U.F., Lehr C.M. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur. J. Pharm. Sci. 14:2001;37-46.
53. Gebert A., Pabst R. M cells at locations outside the gut. Semin. Immunol. 11:1999;165-170.
54. Nicholls T.J., Green K.L., Rogers D.J., Cook J.D., Wolowacz S., Smart J.D. Lectins in ocular drug delivery: an investigation of lectin binding sites on the corneal and conjunctival surfaces. Int. J. Pharm. 138:1996;175-183.
55. Panjwani N., Ahmad S., Raizman M.B. Cell surface glycoproteins of corneal epithelium. Invest. Ophthalmol. Vis. Sci. 36:1995;355-363.
56. Schaeffer H.E., Breitfeller J.M., Krohn D.L. Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux. Invest. Ophthalmol. Vis. Sci. 23:1982;530-533.
57. Goldstein G.W., Betz A.L. The blood-brain barrier. Sci. Am. 255:1986;74-83.
58. Fischer D., Kissel T. Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery. Eur. J. Pharm. Biopharm. 52:2001;1-11.
59. Banks W.A., Kastin A.J. Characterization of lectin-mediated brain uptake of HIV-1 GP120. J. Neurosci. Res. 54:1998;522-529.
60. Ashwell G., Harford J. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51:1982;531-554.
61. Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry. 29:1990;10009-10018.
62. Drickamer K., Taylor M.E. Biology of animal lectins. Annu. Rev. Cell Biol. 9:1993;237-264.
63. Baenziger J.U., Maynard Y. Human hepatic lectin. Physiochemical properties and specificity. J. Biol. Chem. 255:1980;4607-4613.
64. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2:2003;347-360.
65. Julyan P.J., Seymour L.W., Ferry D.R., Daryani S., Boivin C.M., Doran J., David M., Anderson D., Christodoulou C., Young A.M., Hesslewood S., Kerr D.J. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. J. Control. Release. 57:1999;281-290.
66. Seymour L.W., Ferry D.R., Anderson D., Hesslewood S., Julyan P.J., Poyner R., Doran J., Young A.M., Burtles S., Kerr D.J. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J. Clin. Oncol. 20:2002;1668-1676.
67. Yu H.Y., Lin J.H. Intracellular delivery of membrane-impermeable hydrophilic molecules to a hepatoblastoma cell line by asialoglycoprotein- labeled liposomes. J. Formos. Med. Assoc. 99:2000;936-941.
68. Wu C.H., Wilson J.M., Wu G.Y. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J. Biol. Chem. 264:1989;16985-16987.
69. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:1987;4429-4432.
70. Wilson J.M., Grossman M., Cabrera J.A., Wu C.H., Wu G.Y. A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes. J. Biol. Chem. 267:1992;11483-11489.
71. Wu G.Y., Wilson J.M., Shalaby F., Grossman M., Shafritz D.A., Wu C.H. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J. Biol. Chem. 266:1991;14338-14342.
72. Liu G., Molas M., Grossmann G.A., Pasumarthy M., Perales J.C., Cooper M.J., Hanson R.W. Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation. J. Biol. Chem. 276:2001;34379-34387.
73. Martinez-Fong D., Mullersman J.E., Purchio A.F., Armendariz-Borunda J., Martinez-Hernandez A. Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery. Hepatology. 20:1994;1602-1608.
74. Murahashi N., Ishihara H., Sasaki A., Sakagami M., Hamana H. Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes. Biol. Pharm. Bull. 20:1997;259-266.
75. Shimada K., Kamps J.A., Regts J., Ikeda K., Shiozawa T., Hirota S., Scherphof G.L. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochim. Biophys. Acta. 1326:1997;329-341.
76. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. Gene Ther. 2:1995;784-788.
77. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes. Gene. 159:1995;167-174.
78. Arangoa M.A., Duzgunes N., Tros de Ilarduya C. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin- lipoplexes. Gene Ther. 10:2003;5-14.
79. Mathiowitz E.C.I., Donald E. Bioadhesive drug delivery systems-fundamentals, novel approaches and developments. Drugs and the Pharmaceutical Sciences. vol. 98:1999;Marcel Dekker, New York.